Collegium Pharmaceutical Investor Relations Material
Latest events
Q1 2025
Collegium Pharmaceutical
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Collegium Pharmaceutical Inc
Access all reports
Collegium Pharmaceutical Inc. is a specialty pharmaceutical company that focuses on developing and commercializing medications for the treatment of pain and related conditions. The company emphasizes the use of innovative drug delivery technologies to create products designed to address medical needs while minimizing potential risks associated with treatment. The company is headquartered in Stoughton, Massachusetts, and its shares are listed on the NASDAQ.
Key slides for Collegium Pharmaceutical Inc
Q2 2024
Collegium Pharmaceutical Inc
Jefferies Global Healthcare Conference 2025
Collegium Pharmaceutical Inc
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
COLL
Country
🇺🇸 United States